Operator of a biopharma research company intended to develop products to overcome tumor heterogeneity. The company advances novel cancer therapeutics, validating molecular drivers of cancers to lead a...

Healthcare
Dallas, TX, United States
Founded 2018
5 employees
Website
Valuation
$45M
Market implied
Share Price
N/A
Total Raised
$7.2M
Last Round
N/A

Get the full picture

Create a free account to unlock EtiraRx's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required